Vivos Therapeutics, Inc. (VVOS:NASDAQ) closed at $0.131 on October 16, 2026, down 8.19% on the day. The stock trades 95.8% below its 52-week high of $3.11 and 2.4% above its 52-week low of $0.128. Over the past year, it lost 95.5%. Vivos Therapeutics, Inc. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -9.08% | -25.51% | -68.10% | -87.02% | -95.48% |
In 252 trading sessions since October 16, 2025, VVOS closed higher on 98 days (39%). Its best day was June 5, 2026 (+24.82%) and its worst was August 5, 2026 (-26.19%). The stock moved 10% or more in a single session 21 times. It opened at least 5% above the previous day's high 2 times.
Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA). The Vivos treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos oral appliances have been used to treat over 15,000 patients worldwide by more than 1,100 trained dentists.
Find more stocks like VVOS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.